DexCom, Inc.

Equities

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
127 ^USD	-0.85%		-1.03%	+2.39%

Apr. 30	Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	CI
Apr. 26	Wall Street: the worst week of 2024 is followed by the best	CF

Tranche Update on DexCom, Inc.'s Equity Buyback Plan announced on July 28, 2022.

October 27, 2022 at 05:11 pm EDT

From July 26, 2022 to September 30, 2022, the company has repurchased 6,559,178 shares, representing 1.67% for $557.73 million. With this, the company has completed the repurchase of 6,559,178 shares, representing 1.67% for $557.73 million under the buyback announced on July 28, 2022.

Latest news about DexCom, Inc.

Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	Apr. 30	CI
Wall Street: the worst week of 2024 is followed by the best	Apr. 26	CF
Morgan Stanley Adjusts DexCom's Price Target to $132 From $122	Apr. 26	MT
Canaccord Genuity Adjusts Price Target on DexCom to $145 From $144	Apr. 26	MT
Raymond James Adjusts DexCom Price Target to $160 From $151	Apr. 26	MT
Dexcom's profit beats estimates on strong glucose monitor demand	Apr. 25	RE
DexCom, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours	Apr. 25	MT
Transcript : DexCom, Inc., Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Earnings Flash (DXCM) DEXCOM Posts Q1 EPS $0.32, vs. Street Est of $0.27	Apr. 25	MT
Earnings Flash (DXCM) DEXCOM Posts Q1 Revenue $921M, vs. Street Est of $910.9M	Apr. 25	MT
DexCom, Inc. Provides Earnings Guidance for the Year 2024	Apr. 25	CI
John Chevedden Submits a Shareholder Proposal to DexCom	Apr. 22	CI
Myra K. Young Submits a Shareholder Proposal to DexCom	Apr. 22	CI
Dexcom Insider Sold Shares Worth $274,242, According to a Recent SEC Filing	Apr. 16	MT
BTIG Adjusts DexCom's Price Target to $156 From $150	Apr. 15	MT
UBS Raises DexCom's Price Target to $163 From $153, Maintains Buy Rating	Apr. 10	MT
MD Revolution Partners with Dexcom to Integrate Continuous Glucose Monitoring Systems with Its Remote Care Management Platform	Apr. 10	CI
Citigroup Raises Price Target on DexCom to $161 From $148, Keeps Buy Rating	Apr. 03	MT
Dexcom Insider Sold Shares Worth $367,472, According to a Recent SEC Filing	Apr. 01	MT
Dexcom Insider Sold Shares Worth $579,180, According to a Recent SEC Filing	Mar. 26	MT
Dexcom Insider Sold Shares Worth $10,802,803, According to a Recent SEC Filing	Mar. 14	MT
Dexcom Insider Sold Shares Worth $2,715,006, According to a Recent SEC Filing	Mar. 14	MT
Dexcom Insider Sold Shares Worth $1,567,363, According to a Recent SEC Filing	Mar. 14	MT
Dexcom Insider Sold Shares Worth $1,182,680, According to a Recent SEC Filing	Mar. 14	MT

Chart DexCom, Inc.

Duration

Period

More charts

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-21 - Annual General Meeting

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

DexCom is still in the running

March 07, 2024 at 04:49 am EST

More Strategies

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

127 USD

Average target price

150.9 USD

Spread / Average Target

+18.75%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
DEXCOM, INC.	+2.39%	50.96B
ABBOTT LABORATORIES	-4.84%	182B
MEDTRONIC PLC	+0.56%	110B
BECTON, DICKINSON AND COMPANY	-3.35%	67.92B
CENCORA, INC.	+9.36%	44.7B
HOYA CORPORATION	+2.70%	40.66B
METTLER-TOLEDO INTERNATIONAL, INC.	+24.51%	27.6B
WEST PHARMACEUTICAL SERVICES, INC.	+3.43%	26.63B
ZIMMER BIOMET HOLDINGS, INC.	-0.32%	24.98B
TERUMO CORPORATION	+13.67%	24.84B

Other Medical Equipment, Supplies & Distribution